BioCentriq is offering a 4-Day Virtual Training October 19-22 on the design and manufacturing of viral vectors for gene therapy.

As of today, there are still several spots available in Intro to the Design & Manufacturing of Viral Vectors for Gene Therapy.

“Our course is designed to create the workforce of the future “stated Haro Hartounian, Ph.D., senior vice-president and general manager, NJII.  “We must help scientists from around the globe gain a detailed understanding of upstream and downstream processing of viral vectors so they can support the incredible demand we are seeing in the market. “

The course, led by NJII and NJIT staff and faculty, includes 16 hours of interactive, live, on-line instruction held over four days.  It will focus on viral vector theory, technical demonstrations of bioreactors, demonstration of chromatography, principles of tangential flow filtration (TFF) and scale-up topics.

Attendance is limited to 20 scientists and engineers from the industry. Class size is kept small to ensure maximum engagement and interaction.  Attendees must have a basic understanding of cell culture, conventional culture methods and chromatography (affinity, protein capture).

Full details on the course can be found here.

The post Viral Vector Market Projected to Grow Exponentially, Increasing Demand for Skilled Workforce appeared first on NJII.